🔴 Biovie is trading 6.8% down with no clear company-specific catalyst

Biovie is trading 6.8% down at $1.23 on October 13, 2026, with no clear company-specific catalyst identified.

• BioVie’s investor-news page lists its latest release as the September 15 Long COVID trial-results announcement; no October 13 announcement is shown.
• XBI was down 2.01% during the session, while major U.S. indexes were only modestly lower. Sector weakness may have contributed, but does not establish a specific cause for Biovie’s larger decline.